Vivos Therapeutics, Inc. VVOS Q2 2026 earnings

FAQ

When did Vivos Therapeutics, Inc. report Q2 2026 earnings?

Vivos Therapeutics, Inc. (VVOS) reported Q2 2026 earnings on August 14, 2026 after market close.

What were Vivos Therapeutics, Inc.'s Q2 2026 revenue and EPS?

Vivos Therapeutics, Inc. reported revenue of $5.2M and eps of $-0.31 for Q2 2026.

Did Vivos Therapeutics, Inc. beat estimates in Q2 2026?

Revenue missed the consensus estimate of $5.6M by $480.3K. EPS beat the consensus estimate of $-0.41 by $0.10.

How did Vivos Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 34.9% from $3.8M a year earlier and eps grew 43.6% from $-0.55.

Where can I find Vivos Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001493152-26-037173) and the 10-Q periodic report (0001493152-26-038336) directly on SEC EDGAR. The filing index links above go to sec.gov.